Krystal Biotech, Inc. (KRYS) — Dilution Risk Analysis

Current Snapshot

Krystal Biotech, Inc. (KRYS) has a DilutionWatch score of 14/10 and is classified as LOW risk. The score date in the source data is 2026-10-03T03:45:52.527348.

This page is assembled from sourced share-structure, market-data, SEC-filing, and DilutionWatch fields. Missing values are left blank rather than estimated.

Share Structure

Shares Outstanding
29,598,836 Source
Public Float
23,370,371 Source
Float as % of Outstanding
79.0%

Dilution Risk Score

Score: 14/10 Source (as of 2026-10-03T03:45:52.527348)

Recent SEC Filings

Recent filing forms in the source payload: 4 8, 3 2.

FormFiledAccession
4 2026-03-06 0001298709-26-000004
3 2026-03-06 0002114900-26-000003
3 2026-03-06 0002114613-26-000003
4 2026-03-03 0001711279-26-000023
4 2026-03-03 0001298709-26-000002
4 2026-03-03 0001298711-26-000002
4 2026-03-03 0001801385-26-000002
4 2026-02-26 0001711279-26-000021
4 2026-02-23 0001209059-26-000003
4 2026-02-11 0001711279-26-000011

Dilution Risk Drivers

DriverStored ValueSource
Cash runway 999 months Source
Three-year share count growth 4.94% Source

DilutionWatch Analysis

Risk Level
LOW (Score: 14/10) Source
Cash Runway
999 months Source
Share Count Growth (3-Year)
4.94% Source

What This Page Does Not Estimate

DilutionWatch does not infer missing cash runway, authorized share count, ATM capacity, shelf capacity, or share-growth values on this page. A blank field means the current source payload did not provide a usable value with provenance.

Scores and classifications are shown only when supplied by the DilutionWatch data layer. SEC filing rows link to their source accession when a filing URL is available.